Medicare Enrolled
Dr. Kesha Harris-Henderson, M.D.
Radiology - Diagnostic · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harris-Henderson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris-Henderson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harris-Henderson
Dr. Kesha Harris-Henderson is a radiology - diagnostic specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harris-Henderson performed 19,075 Medicare services across 796 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harris-Henderson received a total of $1,622 from 33 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harris-Henderson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in TX
$1,622 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,075
Medicare services
Top 5% in TX for radiology - diagnostic
796
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,004 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
10,600 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
4,590 | $2 | $20 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
585 | $289 | $2,762 |
| CT guidance for radiation therapy This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery. |
581 | $97 | $613 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
498 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 380 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 280 | $1 | $114 |
| Radiation therapy, 3+ areas, 6-10 MeV Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV. |
253 | $190 | $700 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
179 | $69 | $343 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
178 | $152 | $1,067 |
| Calculation of radiation therapy dose | 115 | $53 | $365 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
101 | $23 | $157 |
| Design and construction of complex radiation treatment device This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated. |
94 | $99 | $710 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
92 | $104 | $707 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $11 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $59 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
60 | $48 | $313 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $93 | $368 |
| Complex radiation therapy planning | 38 | $115 | $1,022 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
29 | $12 | $108 |
| Radiation treatment planning, complex This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment. |
25 | $361 | $1,342 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
24 | $218 | $704 |
| X-ray during radiation therapy An X-ray image taken while radiation therapy is being administered to verify treatment positioning. |
24 | $11 | $126 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
23 | $52 | $344 |
| High precision radiation therapy planning This procedure involves the detailed planning and setup required for delivering high-precision radiation therapy to a target area of the body. |
22 | $1,469 | $6,431 |
| Design and construction of radiation treatment device This code covers the design and construction of a device used for high precision radiation therapy. It does not include the actual administration of radiation treatment. |
22 | $372 | $2,640 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $113 | $565 |
| New patient office visit, complex (60-74 min) | 18 | $174 | $709 |
| 3D radiation therapy planning This procedure involves creating a three-dimensional treatment plan for radiation therapy. It uses imaging data to map the target area and surrounding tissues to guide precise radiation delivery. |
15 | $379 | $4,374 |
| Complex radiation therapy planning This procedure involves the detailed planning required to deliver external beam radiation therapy to a patient. |
14 | $223 | $1,126 |
| Design and construction of simple radiation treatment device This code covers the design and construction of a simple radiation treatment device. It does not specify the clinical purpose or condition being treated. |
13 | $31 | $296 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $120 | $496 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
97.7% medium
0.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,622
Total received (2021-2024)
Avg $541/year across 3 years
Top 30% in TX for radiology - diagnostic
33
Companies
69
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,443 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$179 (11.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,507
2023
$103
2021
$12
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$167
Takeda Pharmaceuticals U.S.A., Inc.
$167
PFIZER INC.
$152
Incyte Corporation
$104
Intuitive Surgical, Inc.
$103
Genentech USA, Inc.
$82
AstraZeneca Pharmaceuticals LP
$70
Merck Sharp & Dohme LLC
$68
Janssen Biotech, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$56
Astellas Pharma US Inc
$54
Novartis Pharmaceuticals Corporation
$50
SERVIER PHARMACEUTICALS LLC
$48
SpringWorks Therapeutics, Inc.
$40
ABBVIE INC.
$36
Eisai Inc.
$33
Coherus Biosciences Inc.
$29
Regeneron Healthcare Solutions, Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
Tempus AI, Inc
$24
Genmab U.S., Inc.
$23
Mirati Therapeutics, Inc.
$23
Blueprint Medicines Corporation
$20
GENZYME CORPORATION
$20
Alexion Pharmaceuticals, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$17
Legend Biotech USA Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
Stemline Therapeutics Inc.
$16
ADC Therapeutics America, Inc.
$14
Lilly USA, LLC
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 29.9% of total payments
Associated products mentioned in payments ›
ADVATE · ALUNBRIG · AYVAKIT · Alecensa · Da Vinci Surgical System · ELAHERE · Enhertu · Epkinly · FRUZAQLA · GIVLAARI · IBRANCE · IMFINZI · IMJUDO · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MONJUVI · NINLARO · Nubeqa · OGSIVEO · Orserdu · PLUVICTO · PYRUKYND · Polivy · QINLOCK · REBLOZYL · SARCLISA · Stivarga · TECVAYLI · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Vanflyta · XT CDX · XTANDI · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Radiology - diagnostics within 10 mi
50
Per 100K population
1.9
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Harris-Henderson is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Harris-Henderson experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Harris-Henderson performed 10,600 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harris-Henderson receive payments from pharmaceutical companies?
Yes. Dr. Harris-Henderson received a total of $1,622 from 33 companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris-Henderson's costs compare to other radiology - diagnostics in Dallas?
Dr. Harris-Henderson's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris-Henderson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Radiology - Diagnostics in Dallas
Browse radiology - diagnostics in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Radiology - Diagnostics in TX
Radiology - diagnostics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiology - Diagnostics in TX
Which TX radiology - diagnostics receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology